What to consider in the development of new bone seekers: mechanistic and tracer-related aspects

Nuclear Medicine and Biology

Volumn 35, Issue 8, 2008, Pages 817-824

  Mitterhauser, Markus ^a,b   Toegel, Stefan ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bone scan; Bone seekers; Hydroxyapatite; Polyphosphonate

Indexed keywords

CALCIUM PHOSPHATE; DRUG CARRIER; GALLIUM 68; HYDROXYAPATITE; INDIUM 111; PHOSPHORUS 32; POLYPHOSPHATE; RHENIUM 186; RHENIUM 188; SAMARIUM 153; TECHNETIUM 99M; TRACER; YTTRIUM 90;

BINDING AFFINITY; BONE MATRIX; BONE METASTASIS; BONE SCINTISCANNING; BONE TUMOR; CRYSTALLIZATION; DRUG ACCUMULATION; DRUG BINDING; DRUG DESIGN; DRUG DISTRIBUTION; DRUG SPECIFICITY; DRUG SYNTHESIS; DRUG UPTAKE; HUMAN; IMAGING SYSTEM; LIGAND BINDING; NONHUMAN; REVIEW; STOICHIOMETRY; STRUCTURE ACTIVITY RELATION;

ANIMALS; BONE AND BONES; BONE MATRIX; DURAPATITE; HUMANS; LIGANDS; MAGNETIC RESONANCE IMAGING; ORGANOPHOSPHORUS COMPOUNDS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS;

EID: 56349136920     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2008.09.003     Document Type: Review

References (65)

1. Subramanian G., McAfee J.G., Rosenstreich M., and Coco M. Indium-113 m-labeled polyfunctional phosphonates as bone-imaging agents. J Nucl Med 16 (1975) 1080-1084
2. Billinghurst M.W. Radio ion exchange in bone. In: Billinghurst M.W., and Colombetti L.G. (Eds). Studies of cellular function using radiotracers (1982), CRC Press Inc, Florida 93-114
3. 113mIn-labeled bone scanning agents. Radiology 117 (1975) 727-730
4. 99mTc] Diphosphonate uptake mechanisms on bone. In: Fogelman I. (Ed). Bone scanning in Clinical Practice (1987), Springer, London 7-18
5. Francis M.D., Ferguson D.L., Tofe A.J., Bevan J.A., and Michaels S.E. Comparative evaluation of three diphosphonates: in vitro adsorption (C-14 labeled) and in vivo osteogenic uptake (Tc-99m complexed). J Nucl Med 21 (1980) 1185-1189
6. Chilton H.M., Francis M.D., and Thrall J.H. Radiopharmaceuticals for bone and bone marrow imaging. In: Swanson D.P., Chilton H.M., and Thrall J.H. (Eds). Pharmaceuticals in Medical Imaging (1990), Macmillan Publishing, New York 537-563
7. 99mTc-MDP accumulation mechanisms in bone. Oral Surg Oral Med O 75 (1993) 239-246
8. Nicolay O.F., Heeley J.D., Jeffcoat M.K., and Jones A.G. Autoradiographic localization of technetium-99m methylene diphosphonate in growth sites of young mice. Int J Rad Appl Instrum B 15 (1988) 157-163
9. Beyer G.J., Offord R., Künzi G., Aleksandrova Y., Ravn U., Jahn S., et al. The influence of EDTMP-concentration on the biodistribution of radio-lanthanides and 225Ac in tumor-bearing mice. Nucl Med Biol 24 (1997) 367-372
10. Okamoto Y. Accumulation of technetium-99m methylene diphosphonate. Conditions affecting adsorption to hydroxyapatite. Oral Surg Oral Med O 80 (1995) 115-119
11. 186ReHEDP. Inorg Chem 36 (1997) 3055-3063
12. Blau M., Nagler W., and Bender M.A. Fluorine-18: a new isotope for bone scanning. J Nucl Med 3 (1962) 332-334
13. 18F for bone scanning. Br J Radiol 40 (1967) 655-661
14. Mitterhauser M., and Toegel S. An in-vitro model for the comparative evaluation of bone seeking pharmaceuticals. Altex 25 (2008) 51-55
15. European Pharmacopoeia. 5th edition (2005), published by Council of Europe, Strasbourg
16. 188Re] using different carriers for "cross complexation". Appl Radiat Isot 60 (2004) 653-658
17. Füger B., Mitterhauser M., Wadsak W., Ofluoglu S., Traub T., Karanikas G., et al. Bone lesion detection with carrier added Tc-99m EDTMP in comparison to Tc-99m DPD. Nucl Med Com 25 (2004) 361-365
18. 188Re] on bone compartments: a new model for the pre vivo-evaluation of bone seekers?. Bone 34 (2004) 835-844
19. 188Re] on bone compartments: verification of the pre-vivo model?. Bone 37 (2005) 404-412
20. 90Y]-EDTMP provides evidence for a novel "foreign carrier theory". Nucl Med Biol 33 (2006) 95-99
21. 18F]-fluoride on osteoblasts. Eur J Nucl Med Mol Imaging 33 (2006) 491-494
22. 68Ga]-EDTMP. Nucl Med Biol 34 (2007) 391-397
23. 68Ga]-EDTMP formulations. Eur J Pharm Biopharm 68 (2008) 406-412
24. Betts F., Blumenthal N.C., and Posner A.S. Bone mineralization. J Crystal Growth 53 (1981) 63-73
25. Cuisinier F.J.G. Bone mineralization. Curr Opin Solid State Mater Sci 1 (1996) 436-439
26. Eanes E.D. Crystal growth of mineral phases in skeletal tissues. Prog Cryst Growth Charact 3 (1980) 3-15
27. Robertson W.G., Morgan D.B., Fleisch H., and Francis M.D. The effects of diphosphonates on the exchangeable and non-exchangeable calcium and phosphate of hydroxyapatite. Biochim Biophys Acta 261 (1972) 517-525
28. Huigen Y.M., Krips H.J., Hulleman S., Gelsema W.J., and De Ligny C.L. The adsorption of 99mTc(Sn)-diphosphonate complexes on tri-calciumphosphate: the influence of preparation conditions, ligand-type incubation media and adsorption conditions. The reversibility of the adsorption. Int J Rad Appl Inst Part A 41 (1990) 189-194
29. Toegel S. Preclinical evaluation of bone seeking radiotracer formulations. PhD-Thesis 2007;p46.
30. Schwartz Z., Shani J., Soskolne W.A., Touma H., Amir D., and Sela J. Uptake and biodistribution of technetium-99m-MD32P during rat tibial bone repair. J Nucl Med 34 (1993) 104-108
31. 32P]diphosphonate during endosteal healing around titanium, stainless steel and hydroxyapatite implants in rat tibial bone. Biomaterials 16 (1995) 1373-1380
32. Horiuchi-Suzuki K., Konno A., Ueda M., Fukuda Y., Nishio S., Hashimoto K., et al. Skeletal affinity of Tc(V)-DMS is bone cell mediated and pH dependent. Eur J Nucl Med Mol Imaging 31 (2004) 388-398
33. Wang H., Gerbaudo V.H., Hobbs L.W., and Spector M. Quantitation of osteoblasts-like cell mineralisation on tissue culture polystyrene and Ti-6Al-4V alloy disks by Tc-99m-MDP labelling and imaging in vitro. Bone 36 (2005) 84-92
34. Goeckeler W.F., Edwards B., Volkert W.A., Holmes R.A., Simon J., and Wilson D. Skeletal localization of samarium-153 chelates: potential therapeutic bone agents. J Nucl Med 28 (1987) 495-504
35. Banerjee S., Samuel G., Kothari K., Unni P.R., Sarma H.D., and Pillai M.R.A. Tc-99m and Re-186 complexes of tetraphosphonate ligands and their biodistribution pattern in animal models. Nucl Med Biol 28 (2001) 205-213
36. 177Lu-EDTMP: a potential therapeutic bone agent. Nucl Med Commun 19 (1998) 587-591
37. 105Rh-EDTMP and its bone accumulation. Appl Radiat Isot 52 (2000) 211-215
38. 212Bi-EDTMP synthesis and biodistribution of a novel bone seeking alpha-emitting radiopharmaceutical. J Label Compd Radiopharm 34 (1994) 717-734
39. 227Th-EDTMP: a potential therapeutic agent for bone metastasis. Nucl Med Biol 31 (2004) 901-908
40. 153Sm in rats. Appl Rad Isot 45 (1994) 949-953
41. 166Ho-EDTMP in vivo generator system in mice. Nucl Med Biol 31 (2004) 1079-1085
42. Srivastava S.C., Meinken G.E., Richards P., Som P., Oster Z.H., Atkins H.L., et al. The development and in-vivo behavior of tin containing radiopharmaceuticals-I. Chemistry, preparation, and biodistribution in small animals. Int J Nucl Med Biol. 12 (1985) 167-174
43. Lin W.Y., Hsieh J.F., Lin C.P., Hsieh B.T., Ting G., Wang S.J., et al. Effect of reaction conditions on preparations of rhenium-188 hydroxyethylidene diphosphonate complexes. Nucl Med Biol 26 (1999) 455-459
44. Palmedo H., Guhlke S., Bender H., Sartor J., Schoeneich G., Risse J., et al. Dose escalation study with rhenium-188 hydroxyethylidene biphosphonate in prostate cancer patients with osseous metastases. Eur J Nucl Med 27 (2000) 123-130
45. Hsieh B.T., Hsieh J.F., Tsai S.C., Lin W.Y., Wang S.J., and Ting G. Comparison of various rhenium-188-labeled diphosphonates for the treatment of bone metastases. Nucl Med Biol 26 (1999) 973-976
46. 188Re complexes with aminomethylenephosphonate on hydroxyapatite. J Nucl Radiochem Sci 2 (2001) 5-9
47. 188Re-ethylenediamine-N,N,N′,N′-tetrakis(methylen e phosphonic acid) as a potential agent for bone pain palliation. Nucl Med Comm 23 (2002) 75-81
48. Hosain P. Technetium-99m labelled pyrophosphate: a simple and reproducible bone scanning agent. Br J Radiol 46 (1973) 724-728
49. 99mTc-pyrophosphate as a bone imaging agent. Radiology 109 (1973) 467-468
50. 18F, and skeletal radiography. A comparison of sensitivity. Radiology 107 (1973) 551-555
51. 99mTc-HEDP in normal subjects and in patients with bone tumors. J Nucl Med 16 (1975) 886-890
52. 68Ga-labeled skeletal-imaging agents for positron scintigraphy. J Nucl Med 17 (1976) 1003-1007
53. Dormehl I.C., Louw W.K., Schneeweiss F.H., Milner R., Schmitt G., Carl U., et al. Uptake of ethylenediamine tetramethylene phosphonic acid in normal bone after multiple applications. A non-human primate study. Arzneimittelforschung 48 (1998) 408-414
54. Claessens R.A., and Kolar Z.I. Affinity of Tin(II) and Tin(II) diphosphonates for hydroxyapatite: an experimental and model study. Langmuir 16 (2000) 1360-1367
55. 188Re, and a study of its stability. Appl Radiat Isot 49 (1998) 351-356
56. 99mTc-EHDP complexes. Int J Rad Appl Instrum [A] 38 (1987) 611-614
57. Ghanem N., Kelly T., Altehoefer C., Winterer J., Schafer O., Bley T.A., et al. Whole-body MRI in comparison to skeletal scintigraphy for detection of skeletal metastases in patients with solid tumors. Radiologe 44 (2004) 864-873
58. 99mTc-methylene-diphosphonate scintigraphy in children with suspected multifocal bone lesions. Eur Radiol 14 (2004) 2297-2302
59. Lauenstein T.C., Goehde S.C., Herborn C.U., Goyen M., Oberhoff C., Debatin J.F., et al. Whole-body MR imaging: evaluation of patients for metastases. Radiology 233 (2004) 139-148
60. 99mTc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169 (1997) 1655-1661
61. Daldrup-Link H.E., Franzius C., Link T.M., Laukamp D., Sciuk J., Jurgens H., et al. Whole-body MR imaging for detection of bone metastases in children and young adults: comparison with skeletal scintigraphy and FDG PET. AJR Am J Roentgenol 177 (2001) 229-236
62. Gaa J., Rummeny E.J., and Seemann M.D. Whole-body imaging with PET/MRI. Eur J Med Res 30 (2004) 309-312
63. Engelhard K., Hollenbach H.P., Wohlfart K., von Imhoff E., and Fellner F.A. Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer. Eur Radiol 14 (2004) 99-105
64. Lauenstein T.C., Freudenberg L.S., Goehde S.C., Ruehm S.G., Goyen M., Bosk S., et al. Whole-body MRI using a rolling table platform for the detection of bone metastases. Eur Radiol 12 (2002) 2091-2099
65. Plato. Apology of Socrates. estimated 399-395 B.C.;1:21d.